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Abstract:
Background:
Ferulic Acid (FA) is a phenolic compound that exhibits a wide range of therapeutic effects majorly due to its antioxidant property. There have been
recent  efforts  to  maximize  the  therapeutic  value  of  FA by way of  structural  modification of  FA to  form FA derivatives  in  order  to  enhance
physicochemical, antioxidant and therapeutic prospects.
Objective:
In this work, we synthesized, characterized and evaluated new ferulic derivatives [ferulic phthalate and maleate] for their potential to protect
against CCl4-induced liver injury in Wistar rats.
Methods:
Male Wistar rats were randomly assigned into groups and given oral administration of CCl4 only, or in combination with either ferulic phthalate or
maleate and thereafter, some biochemical parameters (alanine transaminase, aspartate transaminase, alkaline phosphatase and malondialdehyde)
and antioxidant indices (superoxide dismutase, reduced glutathione) were determined.
Results:
Exposure to CCl4 altered liver biochemical indices in particular plasma alanine transaminase activities, in a manner reminiscent of liver injury.
However, ferulic acid, as well as the ferulic derivatives significantly (p<0.05), improved rat liver indices. Also, ferulic derivatives improved
(p<0.05) the rat antioxidant status compared with the group given CCl4 only. Furthermore, ferulic acid and ferulic maleate significantly (p<0.05)
ameliorated rat lipid peroxidation caused by CCl4. Histological studies revealed mild infiltration caused by CCl4 but this cellular distortion was
abated and improved in rats administered with ferulic acid, ferulic phthalate as well as ferulic maleate.
Conclusion:
These findings do not only support the antioxidant as well as the therapeutic potentials of ferulic phthalate and maleate but also the medicinal value
and prospects of phenolic compounds for therapeutic purposes.
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1. INTRODUCTION
Ferulic Acid (FA) is a phenolic compound with important
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antioxidant potential. It is a precursor to many other valuable
phenolics  [1,  2].  It  is  a  ubiquitous phenolic  plant  constituent
that exhibits a wide range of therapeutic effects against cancer,
diabetes,  cardiovascular  and  neurodegenerative  diseases,  on
account of its potent antioxidant capacity [3]. FA is one of the
most  abundant  phenolic  acids  found  in  plants,  many  staple
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foods such as fruits, vegetables, cereals, and coffee [4, 5]. The
antioxidant  property  of  FA  may  be  due  to  the  ability  of  its
hydroxy and phenoxy groups to donate electrons to quench the
free  radicals.  For  example,  the  nucleophilic  groups  on  the
benzene ring (3-methoxy and more importantly, 4- hydroxyl)
of FA give the additional property of terminating free radical
chain  reactions.  Another  functional  group  in  the  FA,  i.e.  the
carboxylic acid group with an adjacent unsaturated C-C double
bond can provide additional attack sites for free radicals and
thus prevent them from attacking the membrane. In addition,
this  carboxylic  acid  group  also  binds  to  the  lipid  bilayer,
providing  some  protection  against  lipid  peroxidation  [6].
There  have  been  increasing  efforts  to  maximize  the
therapeutic benefits of FA. Among such efforts is the structural
modification  of  FA  to  form  FA  derivatives  with  enhanced
physicochemical  and  antioxidant  properties  [7  -  9].  Indeed,
studies have implicated several FA derivatives for therapeutic
potentials, such as anticancer [10 - 12], antiatherogenic [13],
and  antibacterial  agents  [14],  as  well  as  anti-inflammatory
activity [15, 16]. Furthermore, the esterification of FA has also
been widely used to  increase its  biological  potency [17].  FA
ethyl ester is derived by the addition of ethyl groups to FA by
the esterification reaction between FA and ethanol  [18].  The
incorporation of these ethyl groups makes it  more lipophilic,
increasing the ability of this derivative to cross lipid-rich cell
membranes, thereby offering better antioxidant potential [19],
as the membranes such as the blood-brain barrier become more
permeable  and accessible.  Also,  FA methyl  esters  have been
shown  to  be  highly  lipophilic  possessing  greater  antioxidant
activity than the parent compound FA [20, 21]. Isoferulic acid
is another derivative of FA which has been implicated for anti-
diabetic potential [22, 23]. In addition, alkyl ferulates such as
1-hexyl ferulate, 1-heptyl ferulate and 1-pentyl ferulate, have
been demonstrated as possessing a higher inhibitory effect on
linoleic  acid  peroxidation  [8],  while  some  synthesized
derivatives  have  been  observed  to  improve  the  stability  and
absorptions [24].
In the present study, we synthesized and characterized new
FA derivatives and also evaluated them for potential protection
against CCl4-induced liver injury in Wistar rats.
2. MATERIALS AND METHODS
2.1. Chemicals and Reagents
All chemicals and reagents used were of analytical grade
and sourced from Sigma-Aldrich (St Louis, MO, USA). Com-
mercial  reagent  kits  for  the  assay  of  Aspartate  amino-
transferase (AST) and alanine aminotransferase (ALT) were as
supplied  by  Randox  Diagnostics,  Crumlin,  UK.  Ferulic  acid
was obtained from Sigma Aldrich, China (128708-100G Lot #
STB-C5005V).  Where  necessary,  solvents  were  redistilled
prior  to  use.  Thin  Layer  Chromatography  (TLC)  was  per-
formed  using  pre-coated  silica  gel  0.25  mm  60  F254  plates
(Merck, Germany) and developed plates were viewed under the
UV light (254 and 365 nm).
2.2. Synthesis of Ferulic Phthalate (FP) and Ferulic Maleate
(FM)
The  ferulic  acid  derivatives  were  synthesized  following
standard  procedure  [25].  Ferulic  acid  (5  mmol,  194  g)  was
dissolved  in  5%  NaOH,  then  4.44  g  of  phthalic  anhydride
(5mmol,  148  g)  or  1.47  g  Maleate  anhydride  (5mmol,  98  g)
was added gently to the aqueous solution and stirred on ice for
30 minutes. The reaction process was allowed to progress with
constant  monitoring  on  a  Thin  Layer  Chromatograph  (TLC)
plate to completion. The product was purified by washing with
cold  saturated  brine  solution  dried  at  room  temperature  and
stored for further analysis.
2.2.1. Characterization of Synthesized Ferulic Derivatives
Melting points were determined on an Electrothermal, UK,
Melting  point  apparatus.  Absorption  data  was  obtained  on
Beckman  Coulter  DU  730  Life  Sciences,  UK,  UV-Visible
spectrophotometer  while  infrared spectra  were obtained on a
Shimadzu  (8400S)  Fourier  Transform-Infrared  using  KBr
pellet over a 500-4000 cm-1 range. The molecular weight was
determined  on  Mass  Spectrometry  MS-QP  2010  PLUS
(Shimadzu Japan) system coupled with a finigan MAT ion trap
detector operating with Electron Impact (EI) Ionization mode
at a voltage of 70 eV.
2.3. Experimental Animals and Treatment
Thirty-five  (35)  male  Wistar  rats  weighing  between  120
and  150  g  were  randomly  assigned  into  five  groups.  The
animals  were  acclimatized  to  housing  conditions  of  temp-
erature and relative humidity, with a 12 h light/12 h dark cycle.
Water and pellets were provided ad libitum. Group 1 served as
positive control and received carbon tetrachloride (CCl4; 1ml/
kg bw) alone; group 2 served as negative control and received
distilled water only (vehicle; 1ml/ kg bw); while groups 3, 4, 5,
6 and 7 in addition to carbon tetrachloride (1ml/ kg bw) given
on days 1, 3 and 7, received ferulic acid (40 mg/kg bw), ferulic
phthalate or ferulic maleate at 3 or 7 mg/kg bw respectively for
14 days.
The CCl4 dose (1/2 LD50 – 1 ml/kg bw) was selected based
on  a  previous  study  reported  elsewhere  [26],  while  the  dose
selection  for  ferulic  acid  was  based  on  a  report  by  Balasu-
bashini et al. [27] which demonstrated that oral administration
of ferulic acid at 40 mg/kg bw was safe in rats. The treatments
were daily by oral gavage and lasted for 14 days. Handling of
animals was in accordance with Landmark University ethical
guidelines as approved for scientific study, and consistent with
relevant guidelines on the care and use of laboratory animals
[28].
2.3.1. Preparation of Plasma and Liver Homogenates
The rats were sacrificed after 14 days of treatment. Blood
sample was collected in heparinized bottles and centrifuged at
5000 g (Anke TDL-5000B, China) to obtain the plasma. The
liver  was  collected  and  homogenized  in  ice-cold  isotonic
solution (0.25 M sucrose) and further centrifuged to obtain the
supernatant used for biochemical assays.
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2.4. Biochemical Assays
The biochemical parameters were determined in rat plasma
using  a  UV/Vis  spectrophotometer  (Jenway  7205,  Staff-
ordshire,  United  Kingdom)  where  applicable.  The  concen-
trations  of  rat  liver  and  plasma  aspartate  aminotransferase
(AST  –  EC:  2.6.1.1),  alanine  aminotransferase  (ALT  –  EC
2.6.1.2),  were  determined  using  the  Randox  assay  kits
(Crumlin, UK). Alkaline phosphatase (ALP – EC: 3.1.3.1) was
determined using the method described by Wright et al. [29].
Total protein was determined using the Lowry’s method [30].
Malondialdehyde  (MDA)  was  determined  using  the  method
described  by  Niehaus  and  Samuelson  [31].  Reduced  Gluta-
thione  level  (GSH)  was  determined  using  the  procedure
described by Ellman [32], and Akanji et al.  [33]. Superoxide
dismutase  (SOD  –  EC  1.15.1.1)  was  determined  using  the
method  described  by  Misra  and  Fridovich  [34].
2.5. Histopathological Examination
Staining for liver histology was described elsewhere [35].
Briefly,  rat  liver  was fixed in  10% buffered neutral  formalin
immediately  following  excision  from  animals.  The  tissue
fixation and subsequent histopathological processes including
capture and scoring for morphological changes were done by a
pathologist blind to the treatments, at the University of Ilorin
Teaching Hospital, Ilorin, Nigeria. The photomicrographs were
captured  using  the  software,  Presto!  Image  Folio  package
(×400  magnification).
2.6. Data Analysis
Data  were  analyzed  on  GraphPad  Prism  5  (GraphPad
Software Inc. San Diego, California) using one-way analysis of
variance  (ANOVA).  Post-hoc-test  were  conducted  with  the
Dunnett’s  multiple  comparison  test.  Data  are  recorded  as
means of replicates ± Standard Error of Mean (SEM). Group
mean values at p˂ 0.05 were considered significant.
3. RESULTS
3.1. Synthesis and Characterization of Ferulic Maleate and
Ferulic Phthalate
In order to synthesize a bioactive ferulic maleate (Scheme
A) and ferulic phthalate (Scheme B) adducts, ferulic acid (1)
was  treated  with  maleate  anhydride  (2)  in  aqueous  sodium
hydroxide solution in the absence of a protecting group on the
carboxylic  acid.  A  similar  treatment  was  given  to  1  using
phthalic acid (4) to obtain (5). The resulting ferulic maleate (3)
and ferulic  phthalate  (5)  was  purified by washing with  brine
and  purified  product  thereafter  analyzed  using  the  melting
point  apparatus,  Fourier  transform  infrared  and  mass  spect-
rometry.
3.1.1. Ferulic Maleate (3)
White  powder,  m.p.  140-142  oC,  yield  72%,  (Rf  =  0.92,
DCM),  (UV/Vis  =  323  nm,  2.7  abs),  IR  (KBr)  (Vmax,  cm
-1)
3431, 2933, 1685, 1431, 1273, 1209, 1035, 943, 862 and 790, ;
C14H12O7; MW=292.24 MS: m/z (%): 206, 150, 135, 118, 107.
3.1.2. Ferulic Phthalate (5)
White  powder,  m.p.  183-184  oC,  yield  72%,  (Rf  =0.76,
DCM),  (λ  max  =321 nm,  2.7abs),  IR (KBr)  (Vmax,  cm
-1)  3437,,
3014,  1693,  1593,  1514,  1406,  1278,  1207;  C18H14O7;
MW=342.3;  MS:  m/z  (%)  [M-1]+  341.  Other  fragment  ions:
327, 281, 207, 150, 135.
Scheme A. Synthesis of ferulic maleate (3).
Scheme B. Synthesis of ferulic phthalate (5).
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Fig. (1). Effect of administration of Carbon tetrachloride (CCl4), ferulic acid, ferulic maleate and phthalate on the total protein levels of rat liver [A]
and plasma [B]. Data are expressed as the mean ± SEM (n=5). γ is significant at p<0.0001 versus CCl4.
Fig. (2). Effect of administration of Carbon tetrachloride (CCl4), ferulic acid, ferulic maleate and phthalate on alanine aminotransferase (ALT) levels
of rat liver [A] and plasma [B]. Data are expressed as the mean ± SEM (n=5). α is significant at p<0.05, β at p<0.001 and γ at p<0.0001 versus CCl4
and/or CCl4 + FA (40 mg/kg bw).
Fig. (3). Effect of administration of Carbon tetrachloride (CCl4), ferulic acid, ferulic maleate and phthalate on aspartate aminotransferase (AST) levels
of rat liver [A] and plasma [B]. Data are expressed as the mean ± SEM (n=5). α is significant at p<0.05, β at p<0.001 and γ at p<0.0001 versus CCl4
and/or CCl4 + FA (40 mg/kg bw).
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Fig. (4). Effect of administration of Carbon tetrachloride (CCl4), ferulic acid, ferulic maleate and phthalate on alkaline phosphatase (ALP) levels of rat
liver [A] and plasma [B]. Data are expressed as the mean ± SEM (n=5). α is significant at p<0.05, β at p<0.001 and γ at p<0.0001 versus CCl4 and/or
CCl4 + FA (40 mg/kg bw).
Fig. (5). Effect of administration of Carbon tetrachloride (CCl4), ferulic acid, ferulic maleate and phthalate on malondialdehyde (MDA) levels of rat
liver [A] and plasma [B]. Data are expressed as the mean ± SEM (n=5). α is significant at p<0.05 versus CCl4.
Fig. (6). Effect of administration of Carbon tetrachloride (CCl4), ferulic acid, ferulic maleate and phthalate on reduced glutathione (GSH) levels of rat
liver [A] and plasma [B]. Data are expressed as the mean ± SEM (n=5). α is significant at p<0.05 and β at p<0.001 versus CCl4 + FA (40 mg/kg bw).
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Fig. (7). Effect of administration of Carbon tetrachloride (CCl4), ferulic acid, ferulic maleate and phthalate on superoxide dismutase (SOD) levels of
rat liver [A] and plasma [B]. Data are expressed as the mean ± SEM (n=5). β is significant at p<0.001 and γ at p<0.0001 versus CCl4 and/or CCl4 +
FA (40 mg/kg bw).
Fig. (8). Photomicrograph of liver of rats administered with [A] 1 ml/kg bw of carbon tetrachloride (CCl4); [B] Vehicle (distilled water only); [C] 1
ml/kg of CCl4 + 40 mg/kg bw of ferulic acid; [D] 1 ml/kg bw of CCl4 + 3 mg/kg bw of ferulic phthalate; [E] 1 ml/kg of CCl4+7 mg/kg of ferulic
phthalate; [F] 1 ml/kg bw of CCl4 + 3 mg/kg bw of ferulic maleate; [G] 1 ml/kg of CCl4 + 7 mg/kg of ferulic maleate. H & E staining (x400).
3.2. Biochemical Assays
Administration  of  CCl4  alone  significantly  decreased
plasma protein concentration.  But the administration of CCl4
did not alter the rat liver protein concentration compared with
the other treatment groups (Fig. 1a-b). ALT levels in rat liver
of the groups co-administered with either ferulic phthalate or
maleate  at  3  or  7  mg/kg  bw  were  significantly  (p<0.05)
lowered than that of the CCl4 group (Fig. 2a). However, there
was  no  corresponding  increase  in  the  plasma  of  these  same
treatment  groups  as  the  ferulic  acid  and  its  derivatives,
significantly  (p<0.05)  ameliorated  the  increase  in  rat  plasma
level of ALT caused by CCl4 (Fig. 2b). Administration of CCl4
alone did not significantly affect the rat liver AST level relative
to the other treatment groups (Fig. 3a). However, relative to the
CCl4 group, co-treatment with either ferulic phthalate (7 mg/kg
bw) or ferulic maleate (3 mg/kg bw) significantly altered the
rat  plasma  level  of  AST  (Fig.  3b).  Administration  of  CCl4
alone significantly (p<0.05) reduced ALP level in rat liver (Fig.
4a).  However,  the  co-administration  of  CCl4  and  ferulic
maleate (3 and 7 mg/kg bw) or ferulic phthalate (7 mg/kg bw)
significantly increased rat liver ALP level. In contrast, none of
the treatments significantly affected the rat plasma ALP level
(Fig.  4a).  The  CCl4  treatment  alone  elevated  rat  liver  MDA
level but not significantly compared with the other treatment
groups  (Fig.  5a).  Co-treatment  of  CCl4  with  either  ferulic
phthalate or maleate decreased (p>0.05) the level of MDA in
rat  liver.  Furthermore,  the  co-treatment  of  CCl4  with  either
ferulic  phthalate  or  maleate  reduced  rat  plasma  MDA  level
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compared with  CCl4  alone  (Fig.  5b).  Administration  of  CCl4
alone did not significantly affect the level of GSH in rat liver
compared with the other treatment groups (Fig. 6a). Although
co-treatment  of  CCl4  with  either  ferulic  phthalate  or  maleate
increased  the  GSH  level,  the  increase  was  not  significant.
Furthermore, none of the treatments significantly altered the rat
plasma GSH level (Fig. 6b). Administration of CCl4 decreased
rat liver SOD level, though not significantly compared with the
other  treatment  groups  (Fig.  7a).  However,  co-treatment  of
CCl4  with  either  ferulic  phthalate  or  maleate  significantly
elevated rat plasma SOD level compared with CCl4 alone (Fig.
7b).
3.3. Histopathological Examination
The  histopathological  evaluation  of  rat  hepatic  sections
shows  that  CCl4  treatment  alone  caused  infiltration  of  the
hepatic nodule (Fig. 8a). However, ferulic acid, ferulic phtha-
late  or  ferulic  maleate  markedly  improved  the  CCl4-induced
hepatic  distortions  (Fig.  8b-g)  restoring  it  to  near  normal  as
seen with the group given only distilled water.
4. DISCUSSION
Ferulic Acid (FA) is a phenolic compound that exhibits a
wide range of therapeutic effects majorly due to its antioxidant
property.  There  have  been  recent  efforts  to  maximize  the
therapeutic value of FA by way of structural modification of
FA  to  form  FA  derivatives  in  order  to  enhance  physico-
chemical,  antioxidant  and  therapeutic  prospects.  Recent
investigations to maximize the therapeutic benefits of ferulic
acid  have  demonstrated  that  structural  modification  could
enhance  physicochemical  and  antioxidant  property  of  ferulic
acid [7, 8, 17]. To prove the principle, we synthesized two new
derivatives of ferulic acid and evaluated their protective effect
against CCl4-induced liver injury in Wistar rats.
The preparation of ferulic maleate afforded a white powder
which melted over a range 140-142 oC with a yield of 72%. In
the  FT-IR  spectrum,  the  O-H  stretching  of  the  two  terminal
carboxylic  acids  was  observed  as  a  broadband  at  3431  cm-1.
The  characteristic  bands  of  the  aromatic  and  aliphatic  C-H
stretching  appeared  in  the  range  of  3010  and  2933  cm-1
respectively. The appearance of the stretching vibration at 1685
cm-1 corresponding to the carbonyl stretching of ester confirms
the success of the reaction. This agrees with the previous report
[36].  The carbonyl stretching frequency of the ester  has thus
reduced the electron delocalisation of the conjugating pie bond.
The bands which correspond to the C=C stretching, C-H (in-
plane bending) and C-O-C stretching were observed at 1431,
1273 and 1209 cm-1 respectively. Other bands were below the
fingerprint  region.  The  compound  was  subjected  to  mass
spectrometry analysis using the electron impact mode. In the
mass spectrum, the decarboxylation of the two carboxylic acid
followed  by  reduction  afforded  the  ion  peak  at  m/z  206
calculated for C12H14O3 while further cleavage of the ester gave
the  fragment  C9H10O
+  ion  depicted  at  m/z  135.  The  benzene
fragment ion was observed as [C6H6-1]
+ at m/z 77.
The  synthesized  ferulic  phthalate  with  melting  point
183-184oC which was obtained as a white powder had Rf 0.76
when  developed  in  dichloromethane  solvent  system.  The
characteristic  FT-IR  spectra  exhibited  bands  at  3437,  3014,
2910, 1693 cm-1 which corresponds to the O-H, aromatic C-H,
aliphatic C-H and C=O stretchings respectively. The shifting of
the carbonyl stretching to 1693 cm-1 with the corresponding C-
O-C stretching at  1207 cm-1  also confirms the success of  the
synthesis  as  previously  indicated.  In  the  corresponding  mass
spectrum, the molecular ion peak was observed at m/z [M-1]+
341  which  corresponds  to  C18H14O7.  The  reduction  of  the
vinylic carboxylic afforded C18H14O6
+ was observed at m/z 327
while  further  decarboxylation  led  to  the  generation  of  the
pear5k  at  m/z  282  corresponding  to  C17H14O4
+.  The  further
fragmentation of that afforded C9H11O at m/z 135.
Findings show that treatment with CCl4 alone caused mild
liver  injury  as  reflected  in  the  alteration  of  liver  function
indices.  In  particular,  CCl4  appreciably  elevated  rat  plasma
ALT level, a marker enzyme for the evaluation of the integrity
of the liver [37, 38]. The significant (p<0.05) increase in the
plasma ALT levels of the treatment group administered CCl4
alone may be as a result of a compromise in the liver memb-
rane integrity with a corresponding leakage of the enzyme into
the  plasma.  This  finding  also  agrees  with  investigations
reported by Kodovanti  et  al.  [39],  demonstrating the hepato-
toxic  potential  of  CCl4.  Meanwhile,  ferulic  acid  and  its
derivative, ferulic phthalate or maleate significantly (p<0.05)
ameliorated  the  increase  in  plasma  level  of  ALT  caused  by
CCl4 suggesting the potential to protect against liver damage.
In addition, CCl4  alone and co-treatment with FA, FP or FM
inconsistently altered AST and ALP levels. The reason for this
is not known yet. Furthermore, the elevated MDA level caused
by CCl4 indicates lipid peroxidation which might be a fallout of
oxidative cellular damage. The increase in the level of MDA
might be due to the generation of free radicals thereby resulting
in the peroxidation of membrane biomolecules. Moreover, lipid
peroxidation has been implicated in the development of hepatic
injury by the free radical derivatives of CCl4, and this has been
linked  with  cell  membrane  damage  and  consequent  hepato-
toxicity [40]. However, co-treatment of CCl4 with either ferulic
acid  or  ferulic  phthalate  or  maleate  did  reduce  the  level  of
MDA and this reduction was more appreciable in rat plasma.
This  finding  is  consistent  with  an  earlier  report  which
demonstrated that phenolic amide exerted antioxidant action by
inhibiting lipid peroxidation [41]. In addition, a separate report
recently showed that the consumption of polyphenols protected
against  oxidative  damage  in  rats  [42].  Taken  together,  these
findings  further  support  the  medicinal  prospects  of  poly-
phenolic  compounds.
Also, CCl4 has been shown to alter the antioxidant profile
of the liver including the antioxidant enzymes like superoxide
dismutase  (SOD),  catalase  (CAT),  glutathione  peroxidase
(GPx), glutathione reductase (GR), and glutathione transferase
(GST)  [43].  In  the  present  study,  CCl4  did  not  significantly
alter the GSH level, however, it is not impossible that adaptive
mechanism might be at play if we consider that GSH level in
rat liver and plasma were virtually at the same level. The co-
treatment of CCl4 with either ferulic phthalate or maleate did
elevate GSH level though not significantly, which may indicate
the  capability  of  these  ferulic  derivatives  to  boost  adaptive
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antioxidant  status  particularly  in  the  face  of  the  oxidative
onslaught.  This  would  agree  with  the  fact  that  increased
intracellular  GSH may be a response to oxidative stress,  and
thus   reflect   cellular   tolerance  to  oxidizing    environments 
[44,  45].  In  such  a  scenario  of  an  adaptive  response  to
oxidative  stress,  the  GSH  synthesis  and  mobilization  may
increase  in  order  to  dampen  acute  oxidative  onslaught.
SOD  is  a  first  line  defense  antioxidant  enzyme  which
combats O2
•−, converting it into oxygen and hydrogen peroxide
[46]. The significant (p<0.05) increase in SOD levels seen in
the plasma of the treatment groups co-administered CCl4 with
ferulic phthalate or maleate might be an outplay of induction
mechanism put in place for the generation of SOD, in order to
combat the associated reactive species due to CCl4  exposure.
SOD is an inducible enzyme, therefore, elevated levels of SOD
may  partly  indicate  induction  in  response  to  the  presence  of
Reactive Oxygen Species (ROS). This line of opinion would be
consistent with a study reported by Adeyemi et al. [47], who
linked  elevated  SOD  level  to  oxidative  stress  in  rats.
Meanwhile, co-treatment of CCl4 with either FP or FM might
have boosted the induction of SOD in order to counteract the
oxidative assault imposed by exposure to CCl4.
The  histopathological  examination  did  show  that  CCl4
exposure  alone  mildly  distorted  rat  hepatic  architecture.  In
contrast, co-treatment of CCl4 with either ferulic acid or ferulic
phthalate  improved  and  restored  the  rat  hepatic  architecture.
Though  co-treatment  of  CCl4  with  ferulic  maleate  did  not
completely  restore  cellular  architecture  of  rat  liver,  the
improvement  in  biochemical  indices  suggest  that  ferulic
maleate  has the hepatoprotective capability.  Ferulic  acid is  a
phenolic compound with antioxidant property and it is reactive
towards  free  radicals  such  as  reactive  oxygen  species.  Our
findings agree with previous reports of Rukkumani et al. [48]
and  Bacanli  et  al.  [49],  who  demonstrated  that  ferulic  acid
protected against oxidative damage in Wistar rats. Conversely,
this  appears  the  initial  study  demonstrating  the  hepato-
protective effect of ferulic phthalate or maleate in a rat model
of liver injury; however, our findings are in consonance with
existing  investigations  which  revealed  that  synthesized
phenolic  amide  offered  protection  against  lipid  peroxidation
while enhancing hepatic SOD and GSH levels.
CONCLUSION
In the present study, we showed evidence that supports that
FA  maleate  and  FA  phthalate  exhibited  strong  antioxidant
potential as well as protected against drug-induced liver injury
in rats. Our findings do not only support the antioxidant as well
as the therapeutic potential of these FA derivatives but also to
the medicinal value and prospects of phenolic compounds for
therapeutic purposes. The findings showed that ferulic phtha-
late and maleate like their parent compound (ferulic acid), have
potent antioxidant property and protected against CCl4-induced
liver  injury.  More  so,  as  an  indication  of  enhanced  hepato-
protective  effect,  the  ferulic  phthalate  and  maleate  at  lower
doses  (3  and 7  mg/kg bw)  compared favourably  with  ferulic
acid (40 mg/kg bw). However, the protection afforded by these
ferulic derivatives does not appear to be dose-dependent.
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